• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.31% Nasdaq Up1.40%

    Arrhythmia Research Technology Inc. (HRT)

    -NYSE MKT
    7.84 Up 0.18(2.35%) 10:09AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 21,341   20,643   24,306  
    Cost of Revenue18,308  17,849  18,986  
    Gross Profit 3,033   2,794   5,320  
    Operating Expenses
    Research Development335  510  408  
    Selling General and Administrative3,655  4,024  3,683  
    Non Recurring -  1,480  85  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (957) (3,220) 1,143  
    Income from Continuing Operations
    Total Other Income/Expenses Net26  (9)14  
    Earnings Before Interest And Taxes(932)(3,229)1,157  
    Interest Expense319  24  0  
    Income Before Tax(1,251)(3,253)1,157  
    Income Tax Expense2,268  (876)391  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(3,519)(2,377)767  
    Non-recurring Events
    Discontinued Operations(19)(3,761)(2,075)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (3,538) (6,138) (1,309)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (3,538) (6,138) (1,309)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.